OPHLY
Price:
$3.74
Market Cap:
$815.45B
Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER capsules for improvement of the symptoms in patients with pheochromocytoma; and MEKTOVI, VELEXBRU, and ADLUMIZ tablets, as well as BRAFTOVI capsules for malignant tumors. The company also provides GLACTIV and FORXIGA tablets for type 2 diabetes; FORXIGA tablets for the treatment of diabetes; ONOACT injections for tachyarrhythmia; OPALMON ta...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2012-10-02
Stock Exchange
PNK
Ticker
OPHLY
According to Ono Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 843.81B. This represents a change of -10.46% compared to the average of 942.34B of the last 4 quarters.
The mean historical Enterprise Value of Ono Pharmaceutical Co., Ltd. over the last ten years is 1.31T. The current 843.81B Enterprise Value has changed 6.36% with respect to the historical average. Over the past ten years (40 quarters), OPHLY's Enterprise Value was at its highest in in the March 2016 quarter at 2.47T. The Enterprise Value was at its lowest in in the June 2024 quarter at 372.01B.
Average
1.31T
Median
1.28T
Minimum
238.03B
Maximum
2.47T
Discovering the peaks and valleys of Ono Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 89.24%
Maximum Annual Enterprise Value = 2.47T
Minimum Annual Increase = -81.12%
Minimum Annual Enterprise Value = 238.03B
Year | Enterprise Value | Change |
---|---|---|
2024 | 238.03B | -81.12% |
2023 | 1.26T | -12.74% |
2022 | 1.44T | 3.44% |
2021 | 1.40T | 21.94% |
2020 | 1.15T | 9.44% |
2019 | 1.05T | -37.42% |
2018 | 1.67T | 55.86% |
2017 | 1.07T | -56.60% |
2016 | 2.47T | 89.24% |
2015 | 1.31T | 61.30% |
The current Enterprise Value of Ono Pharmaceutical Co., Ltd. (OPHLY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
981.07B
5-year avg
1.10T
10-year avg
1.31T
Ono Pharmaceutical Co., Ltd.’s Enterprise Value is greater than Santen Pharmaceutical Co., Ltd. (458.60B), greater than GSK plc (50.92B), greater than Grifols, S.A. (6.05B), greater than Pfizer Inc. (210.88B), greater than Sanofi (133.10B), greater than Organon & Co. (12.68B), greater than Horizon Therapeutics Public Limited Company (210.00M), greater than GSK plc (52.06B), greater than AstraZeneca PLC (230.26B), greater than Roche Holding AG (234.35B), greater than Novartis AG (222.57B), greater than Merck & Co., Inc. (274.43B), greater than Bristol-Myers Squibb Company (162.91B), greater than Gilead Sciences, Inc. (135.65B), greater than Amgen Inc. (209.71B), greater than Johnson & Johnson (389.36B), greater than AbbVie Inc. (376.52B),
Company | Enterprise Value | Market cap |
---|---|---|
458.60B | $3.54B | |
50.92B | $67.83B | |
6.05B | $6.98B | |
210.88B | $145.36B | |
133.10B | $121.05B | |
12.68B | $3.94B | |
210.00M | $0 | |
52.06B | $69.26B | |
230.26B | $203.49B | |
234.35B | $227.29B | |
222.57B | $204.02B | |
274.43B | $250.89B | |
162.91B | $119.40B | |
135.65B | $112.40B | |
209.71B | $158.32B | |
389.36B | $373.59B | |
376.52B | $312.70B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ono Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ono Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Ono Pharmaceutical Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Ono Pharmaceutical Co., Ltd. (OPHLY)?
What is the 3-year average Enterprise Value for Ono Pharmaceutical Co., Ltd. (OPHLY)?
What is the 5-year average Enterprise Value for Ono Pharmaceutical Co., Ltd. (OPHLY)?
How does the current Enterprise Value for Ono Pharmaceutical Co., Ltd. (OPHLY) compare to its historical average?